Product Images Vecuronium Bromide

This is a warning label for Vecuronium, a paralyzing agent that can cause respiratory arrest. It recommends that Bromide Rxonly Facilities be immediately available for artificial respiration. The package insert should be consulted for dosage and storage instructions. The medication is administered by intravenous injection and the appropriate dosage should be checked on the box. The medication should be reconstituted with supplied bacteriostatic water for injection and used within 24 hours. The rest of the text is unreadable due to errors.*

This text is a label for an injection medication called "Vecuronium Bromide". It includes warnings as it is a paralyzing agent that can cause respiratory arrest. It should only be used in facilities with immediate access to artificial respiration. The medication is for a single intravenous use only and should be discarded if unused. It contains Gentylalcohol and hence is not suitable for use in newborns. The medication should be stored at room temperature or refrigerated, depending on the reconstitution method used. The text also provides information on the manufacturer and distributor of the injection.*

This is a description for a medication called Vecuronium Bromide. The medication comes in injectable form and is primarily used for intravenous use only. The recommended dosage and storage information can be found in the package insert. The medication is available in a 20mg dosage and is required to be reconstituted before use. The reconstitution can be done using bacteriostatic water. The medication should be protected from light to maintain its effectiveness. The company distributing the medication is Varg Paraing and the address is given as Roke Fors, Lo, USA. The text includes some illegible characters.*

This is a description for VECURONIUM BROMIDE FOR INJECTION, which is a paralyzing agent that is distributed by Hospira, Inc. The product is packaged with 10 single-use vials, each containing 20mg of Vecuronium Bromide. The text suggests that the product should be used only for intravenous single use. The molecule should be reconstituted to 20ml using sterile water for injection, resulting in a 1 mg/mL solution. The product contains certain components such as citric acid, sodium phosphate dibasic anhydrous, mannitol USP, and Vecuronium Bromide. The product should be stored dry powder at 68-77°F, protecting from light. If reconstituted with bacteriostatic water for injection, it contains benzyl alcohol, which should not be used in newborns. The product should be used within days and may be stored at room temperature or refrigerated when reconstituted with bacteriostatic water. It's a single-use-only product, and any unused portion must be discarded.*